Ocular Therapeutix OCUL Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Ocular Therapeutix’s reported figures.
The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ocular Therapeutix's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ocular Therapeutix's enterprise value?
- Ocular Therapeutix (OCUL) reported enterprise value of $1.26B in Q1 2026.
- How has Ocular Therapeutix's enterprise value changed year-over-year?
- Ocular Therapeutix's enterprise value increased by 40.8% year-over-year, from $892.18M to $1.26B.
- What is the long-term trend for Ocular Therapeutix's enterprise value?
- Over 5 years (2020 to 2025), Ocular Therapeutix's enterprise value has grown at a 6.8% compound annual growth rate (CAGR), from $1.38B to $1.93B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.